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1. IntroductIon
A number of critical and emergency situations occur 
in which the individual requires first aid measures. When a 
qualified medical person is not available, the recommended 
drug has to be administered by self or by a trained individual to 
reduce the morbidity and mortality. Nerve agent exposure in a 
war scenario and other organophosphorus pesticide poisoning 
require immediate administration of atropine sulphate and 
pralidoxime chloride to reduce the mortality1. These drugs 
can be administered by a self administrable device, the 
autoinjectors2,3. In comparison to manual intramuscular 
injection the autoinjector can deliver the drugs by deep 
intramuscular injection with a spray effect, increasing the area, 
thereby faster drug absorption. The needle is not visible in these 
autoinjectors and the injection will be painless, convenient and 
well suited for mass casualty situations. Healthy volunteers 
were administered atropine and pralidoxime chloride through 
the autoinjectors and it was observed that the absorption of the 
drug was faster by the autoinjector4. 
Only for a few emergency situations the recommended 
drugs are available as autoinjectors. In seizures, anticonvulsants 
are required to reduce the severity and prevent brain damage. 
Midazolam, a water-soluble benzodiazepine agonist has been 
developed as an autoinjector for intramuscular injection5. In 
emergency situation like status epilepticus, diazepam has to be 
administered immediately. The absorption of diazepam given by 
the autoinjector was found to be faster and can be administered 
safely and reliably6. Severe allergy leading to anaphylaxis is 
common due to food, exercise, hymophtera venom and latex. 
Epinephrine is the drug of choice for anaphylaxis and it has 
to be administered promptly using an autoinjector7,8. Migraine 
is characterised by throbbing headache. Sumatriptan is one of 
the preferred drugs for migraine and an autoinjector has been 
developed as an alternative to sumatriptan injection9.
 In military service life during training and operation, low 
intensity conflicts, road accidents and also natural disasters 
situations may occur in which the individual may be seriously 
injured requiring an analgesic and an antibacterial drug for 
field administration by self or by an authorised person10. The 
purpose of this study is to develop amikacin drug cartridge 
for the reusable autoinjector and to study the effect on 
haematological and biochemical changes in response to stress 
induced by its administration through the autoinjector in rat 
and rabbit (rodent and non rodent).
2. MaterIals and Methods
2.1 animals 
Randomly bred Wistar male rats (120 - 200 g) and New 
Zealand White Rabbits of both sexes (1750 - 2250 g), bred 
and maintained at Biomedical Research Unit and Laboratory 
Animal Centre (BRULAC) of Saveetha University were used 
for the study. The rats were kept in polypropylene cages (3 per 
cage) with sterilised and dry paddy husk as a bedding material. 
The rabbits were housed in stainless steel cages (1 per cage). 
The animals were fed with commercial laboratory animal 
feed (Tanuvas, Chennai) and purified water ad libitum. The 
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care and maintenance of the animals were as per the approved 
guidelines of the ‘Committee for the Purpose of Control and 
Supervision of Experiments on Animals’ (CPCSEA, India). 
This study has the approval of Institutional Animal Ethical 
Committee of Saveetha University (SU/SMC/RD/010/2012; 
Dt. 21 February 2012).
2.2 chemicals and drugs 
The amikacin drug cartridge was developed with the 
collaboration of M/s Neon Laboratories (Mumbai), who are the 
technology holders for the development of nerve agent antidote 
cartridges for the autoinjector (Fig. 1). The amikacin cartridge 
was made similar to the atropine sulphate drug cartridge. 
The cartridge contained 250 mg/mL of amikacin as amikacin 
sulphate with stabilisers. The drug volume was 2.3 mL to 2.4 
mL and upon ejection by the autoinjector, 2.1 mL to 2.2 mL 
would be delivered. The other QAQC parameters were as per 
the nerve gas antidote drug cartridge3. The other chemicals 
were either Indian Pharmacopoeia grade or analytical grade, 
purchased from standard companies. Autoinjectors produced 
by M/s Sigma Engineering (Hyderabad), a technology by 
Defence Research and Development Organisation (DRDO) 
and has an option to select full dose delivery or partial dose 
delivery (dual dose autoinjector) was used. 
2.3 experiments in rats
2.3.1 Autoinjector Usage 
The tolerance of the amikacin autoinjector was studied 
by injecting the drug intraperitoneally in rats. For this the drug 
cartridge was diluted 1:4. From the cartridge 1.75 mL of the 
drug solution was withdrawn under a laminar flow and 1.75 mL 
sterile saline was injected back to make the concentration to 63 
mg/mL. The drug cartridge was loaded in the autoinjector with 
the plastic clip restrictor (Fig. 1). This would allow only partial 
volume of the drug (about half) to be injected and restricting 
the ejected needle length to half. The rats were held firmly on 
the surgical table with its back on the table. The autoinjector 
was unlocked and positioned gently on the lower abdomen 
vertically. The trigger button was pressed and held on to the 
abdomen for 10 s. The autoinjector was then removed gently 
and the needle length that was protruding from the cartridge 
was measured. The drug cartridge was weighed before and 
after injection to estimate the quantity of the drug injected. 
For the manual injection the drug solution removed from the 
cartridge was diluted 1:4 with sterile normal saline (63 mg/
mL) and 1 mL was injected intraperitoneally for each rat.
2.3.2 Experimental Groups 
The first experiment was carried out by delivering the drug 
through the autoinjector for 3 consecutive days. The second 
experiment was carried out by delivering the drug through 
autoinjector for 7 consecutive days. The following were the 
groups of this study. For each group 6 rats were used. 
Group A : Control,
Group B : Amikacin injection, 63 mg/mL cartridge for 3 days 
by autoinjector,
Group C : Amikacin injection, 63 mg/mL for 3 days by manual 
injection,
Group D : Amikacin injection, 63 mg/mL cartridge for 7 days 
by autoinjector,
Group E : Amikacin injection, 63 mg/mL for 7 days by manual 
injection.
Group F : Amikacin injection, 63 mg/mL cartridge for 7 days 
by autoinjector, followed by 7 days recovery
Group G : Amikacin injection, 63 mg/mL for 7 days by manual 
injection, followed by 7 days recovery.
2.3.3 Sample Collection 
The animals were weighed daily, and general behaviour, 
food intake and water intake were recorded. Twenty four hours 
after the last injection (4th or the 8th day) blood was withdrawn 
from the orbital sinus of the rats after anaesthetising the animals 
with anaesthetic ether. Blood was collected in two tubes with 
anticoagulant (Na2 EDTA) and without anticoagulant. After 
the collection of the blood the animals were sacrificed with 
over dose of anaesthesia. Vital organs viz., heart, spleen, 
kidney, testis, liver and lung were excised, blotted free of 
blood, weighed and preserved in formalin solution.
2.4 experiments in rabbits
2.4.1 Autoinjector Usage 
The tolerance of the amikacin autoinjector was studied by 
injecting the drug intramuscularly in rabbits. Two doses were 
given to the rabbits (63 mg/mL and 250 mg/mL cartridge). For 
the 63 mg/mL, the drug cartridge was diluted 1:4 as mentioned 
above. The drug cartridge was loaded in the autoinjector with 
the plastic clip restrictor. This would allow only partial volume 
of the drug (about half) to be injected and restricting the ejected 
needle length to half. The rabbits were held firmly on the 
Figure 1. autoinjectors with drug cartridges (a) autoinjector 
with the restrictor for the partial delivery of the drug 
with partially ejected needle. (b) autoinjector with 
fully ejected needle.
(a) (b) 
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surgical table with their side on the table. The autoinjector was 
unlocked and positioned gently on the thigh muscle vertically. 
The trigger button was pressed and held in position for 10 
sec. The autoinjector was then removed gently and the needle 
length that was protruding from the cartridge was measured. 
The drug cartridge was weighed before and after injection to 
estimate the quantity of the drug injected. For the 250 mg/mL, 
the cartridge was used as such.
2.4.2 Experimental Groups and Sample Collection 
Twenty four hours prior to amikacin administration, 
the rabbits were anaesthetised with ketamin (30 mg/kg, i.m.) 
and blood was withdrawn from orbital sinus. Thereafter, the 
injections were given by autoinjector (63 mg/mL or 250 mg/
mL cartridge). The animals were weighed daily, and general 
behaviour, food intake and water intake were recorded. Twenty 
four hours after the last injection (4th day) blood was withdrawn 
from the orbital sinus of the rabbit after anaesthetising the 
animals with ketamin. Blood was collected in two tubes with 
anticoagulant (Na2 EDTA) and without anticoagulant. The 
rabbits were rehabilitated after that. For each dose four rabbits 
were used. 
2.5 haematological Parameters 
The whole blood was used for the estimation of 
haemoglobin (Hb), packed cell volume (PCV), red blood cell 
count (RBC ) and white blood cell count (WBC). Beckman 
Coulter Cell Counter (UK) was used for the analysis. The 
analyses were done at Regenix Super Specialty Laboratory 
(Chennai) as per the equipment manufacturer’s instruction. 
2.6 Biochemical Parameters 
Serum was separated from the blood, and glucose, 
urea, creatinine, aspartate aminotransferase (AST), alanine 
amonitransferase (ALT), gama glutamyl transferase (GGT) and 
lactic dehydrogenase (LDH) were estimated. For the analyses 
Roche Modular EVO 9000 autoanalyser (USA) was used. The 
analyses were done at Regenix Super Specialty Laboratory 
(Chennai) as per the equipment manufacturer’s instruction.
2.7 organ to Body Weight ratio 
The organ to body weight index (OBWI) in rats was 
calculated as a ratio of organ weight divided by body weight 
and multiplied by 100. The tissues were fixed in formalin 
solution and preserved for histological studies. 
2.8 statistical analysis 
All the parameters were analysed using one way analysis 
of variance and compared with control using Dunnett’s test 
in the rat experiment. Paired ‘t’ test was used in the rabbit 
experiment. A probability of 0.05 and less was taken as 
statistically significant. The analysis and plotting of graphs 
were carried out using SigmaPlot 12 (Systat Software Inc., 
USA).  
 
3. results and dIscussIon
3.1 experiments in rats
In one rat full dose of 500 mg of amikacin was injected 
intraperitoneally through the autoinjector (full needle length). 
The animal died within 1 hour. In two rats partial dose of 250 
mg was injected intraperitoneally (partial needle). The delivery 
of the drug was perfect and the animals did not react. The rats 
survived after the first dose and a second dose of 250 mg was 
administered intraperitoneally through the autoinjector the next 
day. Both the rats died within 4 hours. Hence, the cartridge 
was diluted 1:4 (63 mg/mL) and 3 injections were given on 
consecutive days. As the animals responded very well a second 
experiment was carried out by administering the drug for 7 days 
consecutively. Based on the amount of solution injected and 
the weight of the animal the injected dose was calculated. Four 
autoinjectors were used in this study and the dose injected per 
day for the rats was 546.0 ± 15.5, 515.3 ± 23.6, 496.6 ± 39.7 
and 494.2 ± 26.1 (mean ± SE) mg/kg respectively for the four 
autoinjectors. The dose administered was not significant from 
each other. The average dose injected in the rats was 511.5 
± 16.2 (mean ± SE) mg/kg. Using the restrictor the effective 
needle length was 15.54 ± 0.09 mm (partial needle). Without 
the restrictor the effective needle length was 26.42 ± 0.09 mm 
(full needle).
The food consumption, water intake, general behaviour 
and body weight of the rats did not show any significant 
difference among the groups. Upon opening the abdomen no 
sign of bleeding or injury was observed, due to the autoinjector 
or the manual injection. Figure 2 shows the OBWI of 3 day and 
7 day treatment. There was no significant difference between 
Figure 2. organ to body weight ratio (g/100 g) of rats after 
3 days and 7 days administration of amikacin by 
autoinjector and by manual injection.
Note: a = Control, b = 3 days Autoinjector delivery, c = 3 days 
manual injection, d = 7 days Autoinjector delivery, e = 7 days manual 
injection. f = 7 days Autoinjector delivery with 7 days recovery, g 
= 7 days manual injection with 7 days recovery. Mean ± SE, n =6. 
*Significantly different from control.
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mL cartridge group showed a significant decrease in Hb, PCV 
and RBC count, and no change in WBC count. The serum 
parameters viz., glucose, urea and creatinine did not show any 
significant difference compared to pre administration levels 
in the 63 mg/mL and 250 mg/mL cartridge groups, but the 
creatinine level was significantly increased in the 250 mg/mL 
cartridge group in the post administration (Fig. 7). The serum 
enzymes AST, ALT, GGT and LDH also did not show any 
significant difference in post administration compared to the 
pre administration (Fig. 8).
4. dIscussIon
Aminoglycosides are potent bactericidal antibiotics that act 
by binding to 30 s ribosomal subunits. They are particularly active 
against aerobic, gram-negative bacteria and act synergistically 
against certain gram-positive organisms. Amikacin is a safer 
antibiotic and effective against gentamycin resistant organisms11. 
Amikacin sulphate is water soluble and stable, and hence used 
for preparing the drug cartridge. Since the adult intramuscular 
dose is 500 mg the cartridges were made with the same dose and 
diluted for the animal usage. The front septum of the cartridge is 
made of silicon (~30 shore hardness) and withdrawing the liquid 
from the cartridge and injecting sterile saline using a 22 gauge 
needle was effective, as there was no leak while ejecting the 
Figure 3. haematological parameters of rats after 3 days and 
7 days administration of amikacin by autoinjector 
and by manual injection. 
Note: a = Control, b = 3 days Autoinjector delivery, c = 3 days 
manual injection, d = 7 days Autoinjector delivery, e = 7 days manual 
injection. . f = 7 days Autoinjector delivery with 7 days recovery, g = 
7 days manual injection with 7 days recovery. Mean ± SE, n =6.
the control group, the groups of autoinjector and the groups of 
manual injection, except the kidney weight was significantly 
higher in the autoinjector 7 day recovery group. Figure 3 
shows the level of Hb, PCV, RBC count and WBC count. No 
significant difference was observed between all the groups. 
The serum parameters viz., glucose, urea and creatinine did not 
show any significant difference compared to control (Fig. 4). 
Similarly the enzymes AST, ALT, GGT and LDH also did not 
show any significant difference from the control (Fig. 5). 
3.2 experiments in rabbits
One autoinjector was used for administering the amikacin 
to the rabbits. The average dose injected per day for the rabbit 
was 56.0 ± 4.4 mg/kg (mean ± SE) with 63 mg/mL cartridge 
and 189.2 ± 8.2 mg/kg (mean ± SE) with 250 mg/mL cartridge. 
Using the restrictor the effective needle length was 15.79 ± 
0.11 mm (partial needle). The food consumption, water intake, 
general behaviour and body weight of the rabbits did not 
show any apparent change in the 63 mg/mL cartridge group 
but the 250 mg/mL cartridge group showed sluggish activity. 
Figure 6 shows the level of Hb, PCV, RBC count and WBC 
count. No significant difference was observed in the 63 mg/
mL cartridge group between the pre and post administration 
of amikacin, except an increase in WBC count. The 250 mg/
Figure 4. Biochemical parameters of rats after 3 days and 7 
days administration of amikacin by autoinjector and 
by manual injection. 
Note: a = Control, b = 3 days Autoinjector delivery, c = 3 days 
manual injection, d = 7 days Autoinjector delivery, e = 7 days manual 
injection.. f = 7 days Autoinjector delivery with 7 days recovery, g = 7 
days manual injection with 7 days recovery.  Mean ± SE, n =6.  
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Figure 5. serum enzyme levels of rats after 3 days and 7 days 
administration of amikacin by autoinjector and by 
manual injection. 
Note: a = Control, b = 3 days Autoinjector delivery, c = 3 days 
manual injection, d = 7 days Autoinjector delivery, e = 7 days manual 
injection, f = 7 days Autoinjector delivery with 7 days recovery, g = 7 
days manual injection with 7 days recovery. Mean ± SE, n =6.
liquid from the cartridge by the autoinjector. The autoinjector 
with the provision for two doses also functioned satisfactorily. 
The full dose is expected to deliver a volume of 2.1 to 2.2 mL 
and the new design of a restrictor in the autoinjector delivered 
a partial volume of 1.2 to 1.3 mL. The four autoinjectors used 
in this study also showed same quantity of drug delivery. The 
injectable needle length was within the range and recommended 
for the autoinjector devices12,13. The autoinjectors meant for 
intramuscular injection in human being was used in the study 
with a modification of two volume deliveries - full volume 
injection and partial volume injection. In the partial volume 
injection the needle length is in the range of 15 mm – 16 mm. 
It is not possible to give intramuscular injection in rats as the 
muscle mass is small. Hence intraperitoneal injection was used 
to study whether the forceful injection cause any tissue injury 
in the abdomen. But, in rabbits as the muscle mass is thicker 
intramuscular injection was given.
The reported LD50 of amikacin is 3.5 g/kg by 
intraperitoneal injection in rat (Material Safety Data Sheet). 
Since the human dose is close to the LD50 of rat the full dose 
of 500 mg and the partial dose of 300 mg (2 doses) could not 
be tolerated by the rats. But, a drug like atropine sulphate was 
Figure 6. haematological parameters of rabbits after 3 days 
administration of amikacin by autoinjector.
Note: ‘a’ before (Control) and ‘b’ after 63 mg/rabbit of amikacin 
administration by Autoinjector. ‘c’ before (Control) and ‘d’ after 250 
mg/rabbit of amikacin administration by Autoinjector. Mean ± SE, n 
=4, *Significantly different from respective control by paired ‘t’ test.
Figure 7. Biochemical parameters of rabbits after 3 days 
administration of amikacin by autoinjector.
Note: ‘a’ before (Control) and ‘b’ after 63 mg/rabbit of amikacin 
administration by Autoinjector. ‘c’ before (Control) and ‘d’ after 250 
mg/rabbit of amikacin administration by Autoinjector. Mean ± SE, n 
=4, *Significantly different from respective control y paired ‘t’ test.
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Figure 8. serum enzyme levels of rabbits after 3 days 
administration of amikacin by autoinjector. 
Note: ‘a’ before (Control) and ‘b’ after 63 mg/rabbit of amikacin 
administration by Autoinjector. ‘c’ before (Control) and ‘d’ after 250 
mg/rabbit of amikacin administration by Autoinjector. Mean ± SE, n 
=4.
tolerated by pigs when the human dose was administered by 
autoinjectors14. In the experimental dose (63 mg/mL cartridge) 
none of the haematological and biochemical parameters 
showed any significant difference compared with the control, 
manual injection and through autoinjector when administered 
to rat intraperitoneally, showing that the delivery of amikacin 
through the autoinjector was well tolerated by the rats. 
Amikacin is known to cause ototoxicity and nephrotoxicity 
upon long term usage15. The serum urea and creatinine levels 
showed no significant difference, demonstrating that the dose 
and duration used in this study did not cause nephrotoxicity in 
rats. 
However, in the rabbit intramuscular model the low dose 
(63 mg/mL cartridge) did not show any effect, but the higher 
dose (250 mg/mL cartridge) increased the levels of creatinine 
demonstrating that this dose may cause nephrotoxicity. The 
haematological parameters did not show any significant change 
in the rat intraperitoneal injection or the rabbit (63 mg/mL 
cartridge) intramuscular injection. But the higher dose (250 
mg/mL cartridge) showed toxicity. Unlike the rat study, in the 
rabbit manual injection was not carried out. Never the less, the 
toxicity may be due to amikacin and not due to the autoinjector 
force. Since, the delivery of the drugs intramuscularly by 
autoinjector is expected to be close to intravenous, the higher 
dose could have caused nephrotoxicity. The reported LD50 
of amikacin by intramuscular route is 3000 mg/kg and by 
intravenous route is 260 mg/kg in rabbits. The liver enzymes 
did not show any significant difference from the control 
showing that the injection with the autoinjector which delivers 
the drug with a force did not cause any tissue damage. All the 
vital organs studied did not exhibit any gross abnormality as 
the OBWI did not show any significant difference in rat. 
This study shows that intraperitoneal injection of amikacin 
by the autoinjector designed for intramuscular injection was 
well tolerated by the rats. In the rabbits, low dose (63 mg/mL) 
was tolerated while the higher dose, which is an adult human 
dose (250 mg/mL) showed significant changes. The reusable 
autoinjector with dual dose provision also functioned very 
effectively. It is also possible to decrease the drug concentration 
by dilution with normal saline inside the cartridge aseptically 
and hence the autoinjector can be used for children. 
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